Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations

被引:71
作者
Erickson, RP
Dagenais, SL
Caulder, MS
Downs, CA
Herman, G
Jones, MC
Kerstjens-Frederikse, WS
Lidral, AC
McDonald, M
Nelson, CC
Witte, M
Glover, TW
机构
[1] Univ Arizona, Hlth Sci Ctr, Steele Mem Childrens Res Ctr, Angel Charity Children Wings Genet Res, Tucson, AZ 85724 USA
[2] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, Dept Ophthalmol, Ann Arbor, MI 48109 USA
[5] Ohio State Univ, Coll Med & Publ Hlth, Dept Pediat, Columbus, OH 43210 USA
[6] Univ Calif San Diego, Childrens Hosp & Hlth Ctr, San Diego, CA 92103 USA
[7] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA
[8] Univ Groningen Hosp, NL-9713 EZ Groningen, Netherlands
[9] Ohio State Univ, Coll Dent, Sect Orthodont, Columbus, OH 43210 USA
[10] Duke Univ, Dept Pediat, Durham, NC 27706 USA
[11] Univ Arizona, Hlth Sci Ctr, Dept Surg, Tucson, AZ 85724 USA
关键词
lymphoedema; distichiasis; forkhead gene; clinical heterogeneity;
D O I
10.1136/jmg.38.11.761
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background-Hereditary lymphoedema-distichiasis (LD) is an autosomal dominant disorder that classically presents as lymphoedema of the limbs, with variable age of onset, and extra aberrant growth of eyelashes from the Meibomian gland (distichiasis). Other major reported complications include cardiac defects, cleft palate, and extradural cysts. Photophobia, exotropia, ptosis, congenital ectropion, and congenital cataracts are additional eye findings. Recently, we reported that truncating mutations in the forkhead transcription family member FOXC2 resulted in LD in two families. Methods-The clinical findings in seven additional families with LD, including the original family described by Falls and Kertesz, were determined and mutational analyses were performed. Results-Distichiasis was the most common clinical feature followed by age dependent lymphoedema. There is a wide variation of associated secondary features including tetralogy of Fallot and cleft palate. The mutational analyses identified truncating mutations in all of the families studied (two nonsense, one deletion, three insertion, and one insertion-deletion), which most likely result in haploinsufficiency of FOXC2. Conclusions-FOXC2 mutations are highly penetrant with variable expressivity which is not explicable by the pattern of mutations.
引用
收藏
页码:761 / 766
页数:6
相关论文
共 28 条
  • [1] BELL R, IN PRESS HUM GENET
  • [2] CORBETT CRR, 1982, LYMPHOLOGY, V15, P85
  • [3] Mapping of primary congenital lymphedema to the 5q35.3 region
    Evans, AL
    Brice, G
    Sotirova, V
    Mortimer, P
    Beninson, J
    Burnand, K
    Rosbotham, J
    Child, A
    Sarfarazi, M
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (02) : 547 - 555
  • [4] FALLS H F, 1964, Trans Am Ophthalmol Soc, V62, P248
  • [5] Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome
    Fang, JM
    Dagenais, SL
    Erickson, RP
    Arlt, MF
    Glynn, MW
    Gorski, JL
    Seaver, LH
    Glover, TW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (06) : 1382 - 1388
  • [6] Truncating mutations in FOXC2 cause multiple lymphedema syndromes
    Finegold, DN
    Kimak, MA
    Lawrence, EC
    Levinson, KL
    Cherniske, EM
    Pober, BR
    Dunlap, JW
    Ferrell, RE
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (11) : 1185 - 1189
  • [7] Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development
    Gale, NW
    Yancopoulos, GD
    [J]. GENES & DEVELOPMENT, 1999, 13 (09) : 1055 - 1066
  • [8] DISTICHIASIS, CONGENITAL HEART-DEFECTS AND MIXED PERIPHERAL VASCULAR ANOMALIES
    GOLDSTEIN, S
    QAZI, QH
    FITZGERALD, J
    GOLDSTEIN, J
    FRIEDMAN, AP
    SAWYER, P
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1985, 20 (02): : 283 - 294
  • [9] Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase
    Irrthum, A
    Karkkainen, MJ
    Devriendt, K
    Alitalo, K
    Vikkula, M
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (02) : 295 - 301
  • [10] Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
    Jeltsch, M
    Kaipainen, A
    Joukov, V
    Meng, XJ
    Lakso, M
    Rauvala, H
    Swartz, M
    Fukumura, D
    Jain, RK
    Alitalo, K
    [J]. SCIENCE, 1997, 276 (5317) : 1423 - 1425